These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20886673)

  • 1. Triptan therapy in migraine.
    Shaffer CR
    N Engl J Med; 2010 Sep; 363(14):1377; author reply 1378. PubMed ID: 20886673
    [No Abstract]   [Full Text] [Related]  

  • 2. Transient global amnesia, migraine, thalamic infarct, dihydroergotamine, and sumatriptan.
    Pradalier A; Lutz G; Vincent D
    Headache; 2000 Apr; 40(4):324-7. PubMed ID: 10759939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [First generic triptan approved].
    MMW Fortschr Med; 2006 Apr; 148(16):62-3. PubMed ID: 16688954
    [No Abstract]   [Full Text] [Related]  

  • 4. Is sumatriptan use safe during pregnancy?
    Evans RW; Diamond ML
    Headache; 2000; 40(10):856-7. PubMed ID: 11135034
    [No Abstract]   [Full Text] [Related]  

  • 5. Tolerability of sumatriptan: clinical trials and postmarketing experience.
    Allen C; Dayno J
    Cephalalgia; 2001 Oct; 21(8):855-6. PubMed ID: 11737014
    [No Abstract]   [Full Text] [Related]  

  • 6. Vasospasm induced myocardial ischaemia secondary to sumatriptan use.
    Okonkwo K; Ojha U
    BMJ Case Rep; 2020 Aug; 13(8):. PubMed ID: 32843411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Headache.
    Vijayan N
    West J Med; 1995 Nov; 163(5):474-5. PubMed ID: 8533416
    [No Abstract]   [Full Text] [Related]  

  • 8. The site of common side effects of sumatriptan.
    Solomon S; Lipton RB; Newman LC
    Headache; 1997 May; 37(5):289-90. PubMed ID: 9195768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of efficacy and tolerance sumatriptan at a dose of 50 mg in treatment of migraine attack].
    Prusiński A; Król F
    Pol Merkur Lekarski; 1998 Mar; 4(21):158-61. PubMed ID: 9640070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Looking forward: the expanding utility of sumatriptan and naratriptan.
    Cady R
    Cephalalgia; 2001; 21 Suppl 1():35-8. PubMed ID: 11678821
    [No Abstract]   [Full Text] [Related]  

  • 11. Triptans and migraine.
    Bateman DN
    Lancet; 2000 Mar; 355(9207):860-1. PubMed ID: 10752697
    [No Abstract]   [Full Text] [Related]  

  • 12. Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment.
    Göbel H; Heinze A; Stolze H; Heinze-Kuhn K; Lindner V
    Cephalalgia; 1999 Sep; 19(7):676-83; discussion 626. PubMed ID: 10524662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous sumatriptan compared with usual acute treatments for migraine: clinical and pharmacoeconomic evaluation.
    Laloux P; Vakaet A; Monseu G; Jacquy J; Bourgeois P; van der Linden C
    Acta Neurol Belg; 1998 Dec; 98(4):332-41. PubMed ID: 9922821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective large-scale study of the tolerability of subcutaneous sumatriptan injection for acute treatment of migraine.
    O'Quinn S; Davis RL; Gutterman DL; Pait GD; Fox AW
    Cephalalgia; 1999 May; 19(4):223-31; discussion 200. PubMed ID: 10376167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ST-Elevation Myocardial Infarction After Sumitriptan Ingestion in Patient with Normal Coronary Arteries.
    Jensen C; Riddle M
    West J Emerg Med; 2015 Sep; 16(5):781-3. PubMed ID: 26587110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The specific treatment of migraine: a story about one triptan.
    Tabeeva GR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(5):75-8. PubMed ID: 18686370
    [No Abstract]   [Full Text] [Related]  

  • 17. Sumatriptan and naratriptan tolerability and safety: an update of post-marketing experience.
    Welch KM
    Cephalalgia; 2001; 21 Suppl 1():25-8. PubMed ID: 11678818
    [No Abstract]   [Full Text] [Related]  

  • 18. [Choice of triptan in migraine].
    Salvesen R
    Tidsskr Nor Laegeforen; 2001 Nov; 121(29):3410-1. PubMed ID: 11826788
    [No Abstract]   [Full Text] [Related]  

  • 19. Migraine polypharmacy and the tolerability of sumatriptan: a large-scale, prospective study.
    Putnam GP; O'Quinn S; Bolden-Watson CP; Davis RL; Gutterman DL; Fox AW
    Cephalalgia; 1999 Sep; 19(7):668-75. PubMed ID: 10524661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Building on the sumatriptan experience: the development of naratriptan.
    Connor HE
    Cephalalgia; 2001; 21 Suppl 1():32-4. PubMed ID: 11678820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.